IUHSA
Itau Unibanco Holding S.A. Portfolio holdings
AUM
$2.63B
1-Year Return
21.65%
This Quarter Return
-2.93%
1 Year Return
+21.65%
3 Year Return
+79.74%
5 Year Return
+135.75%
10 Year Return
–
AUM
$1.86B
AUM Growth
-$168M
(-8.3%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-7.21%
Top 10 Holdings %
Top 10 Hldgs %
55.33%
Holding
450
New
108
Increased
193
Reduced
52
Closed
79
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$89.8M |
| 2 |
Vale
VALE
|
$54.4M |
| 3 |
Itaú Unibanco
ITUB
|
$50.9M |
| 4 |
America Movil
AMX
|
$32.4M |
| 5 |
Walt Disney
DIS
|
$25.7M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$222M |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
$117M |
| 3 |
Petrobras Class A
PBR.A
|
$91.8M |
| 4 |
Petrobras
PBR
|
$55M |
| 5 |
iShares MSCI Japan ETF
EWJ
|
$53.1M |
Sector Composition
| 1 | Communication Services | 11.42% |
| 2 | Technology | 8.16% |
| 3 | Materials | 7.39% |
| 4 | Consumer Discretionary | 6.73% |
| 5 | Financials | 6.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Pentair
PNR
$18.1B
| $22K | ﹤0.01% |
+303
| New | +$22K |
|
327
Maravai LifeSciences
MRVI
$363M
| $21K | ﹤0.01% |
435
+11
| +3% | +$531 |
|
328
Arrowhead Research
ARWR
$4.02B
| $20K | ﹤0.01% |
316
+8
| +3% | +$506 |
|
329
lululemon athletica
LULU
$19.9B
| $20K | ﹤0.01% |
49
| – | – |
|
330
NeoGenomics
NEO
$1.03B
| $20K | ﹤0.01% |
422
+11
| +3% | +$521 |
|
|
OCFT
331
OneConnect Financial Technology
OCFT
$281M
| $20K | ﹤0.01% |
493
+169
| +52% | +$6.86K |
|
332
Essential Utilities
WTRG
$11B
| $20K | ﹤0.01% |
+433
| New | +$20K |
|
|
NVTA
333
DELISTED
Invitae Corporation
NVTA
| $20K | ﹤0.01% |
702
-10
| -1% | -$285 |
|
334
Denali Therapeutics
DNLI
$2.26B
| $19K | ﹤0.01% |
379
+10
| +3% | +$501 |
|
335
Neurocrine Biosciences
NBIX
$14.3B
| $19K | ﹤0.01% |
203
+6
| +3% | +$562 |
|
|
AXDX
336
DELISTED
Accelerate Diagnostics
AXDX
| $18K | ﹤0.01% |
316
+108
| +52% | +$6.15K |
|
337
Sarepta Therapeutics
SRPT
$1.96B
| $18K | ﹤0.01% |
191
+5
| +3% | +$471 |
|
338
Fate Therapeutics
FATE
$116M
| $17K | ﹤0.01% |
279
+8
| +3% | +$487 |
|
339
Match Group
MTCH
$9.18B
| $17K | ﹤0.01% |
111
-1
| -0.9% | -$153 |
|
340
Sunrun
RUN
$4.19B
| $17K | ﹤0.01% |
386
-34,314
| -99% | -$1.51M |
|
341
Advanced Drainage Systems
WMS
$11.5B
| $17K | ﹤0.01% |
+156
| New | +$17K |
|
342
Applied Materials
AMAT
$130B
| $16K | ﹤0.01% |
124
-102
| -45% | -$13.2K |
|
343
CareDx
CDNA
$736M
| $16K | ﹤0.01% |
252
+7
| +3% | +$444 |
|
344
Fiserv
FI
$73.4B
| $16K | ﹤0.01% |
150
-75
| -33% | -$8K |
|
345
TopBuild
BLD
$12.3B
| $14K | ﹤0.01% |
+67
| New | +$14K |
|
346
Graphic Packaging
GPK
$6.38B
| $14K | ﹤0.01% |
+710
| New | +$14K |
|
347
Integra LifeSciences
IART
$1.25B
| $14K | ﹤0.01% |
203
+5
| +3% | +$345 |
|
348
Polaris
PII
$3.33B
| $14K | ﹤0.01% |
+116
| New | +$14K |
|
349
TG Therapeutics
TGTX
$5.11B
| $14K | ﹤0.01% |
407
+10
| +3% | +$344 |
|
350
Vornado Realty Trust
VNO
$7.93B
| $14K | ﹤0.01% |
+330
| New | +$14K |
|